1-4 of 4
Douglas E. Joshua, MD
Close
Sort by
Journal Articles

Differentiation of Multiple Myeloma and MGUS by Cross Validated Differential Proteomic Analysis.

Ross D. Brown, PhD, Larissa Belov, PhD, Cris dos Remedios, PhD, Daniel Sze, PhD, Simon Cooper, Mila Dolotin, John Gibson, MD, Douglas E. Joshua, MD
Journal: Blood
Blood (2006) 108 (11): 3524.
https://doi.org/10.1182/blood.V108.11.3524.3524
Published: 2006
Journal Articles

Gene Expression Profiling of the Clinical Significant CD57 + CD8 + Cytotoxic T Cell Expansions in Patients with Waldenstrom’s Macroglobulinemia.

Daniel Sze, PhD, Tetsuo Yamagishi, BSc, Warren Kaplan, PhD, Ross D. Brown, PhD, Phoebe Joy Ho, MD, John Gibson, MD, Douglas E. Joshua, MD
Journal: Blood
Blood (2006) 108 (11): 3395.
https://doi.org/10.1182/blood.V108.11.3395.3395
Published: 2006
Journal Articles

Identification and Characterization of Cancer Stem Cells in Multiple Myeloma.

Daniel Sze, PhD, Yen S. Loh, BSc, Suilin Mo, MSc, Warren Kaplan, PhD, Ross D. Brown, PhD, Phoebe Joy Ho, MD, John Gibson, MD, Douglas E. Joshua, MD
Journal: Blood
Blood (2006) 108 (11): 512.
https://doi.org/10.1182/blood.V108.11.512.512
Published: 2006
Journal Articles

The Immunomodulatory Action of Thalidomide in Patients with Multiple Myeloma Involves a Clonal Expansion of Late-Differentiated Cytotoxic Effector Cells.

Ross D. Brown, PhD, Allan Murray, Daniel M. Sze, PhD, Andrew Spencer, MD, Phoebe Joy Ho, MD, John Gibson, MD, Douglas E. Joshua, MD
Journal: Blood
Blood (2005) 106 (11): 5108.
https://doi.org/10.1182/blood.V106.11.5108.5108
Published: 2005